Copyright
©The Author(s) 2023.
World J Clin Cases. Apr 6, 2023; 11(10): 2140-2159
Published online Apr 6, 2023. doi: 10.12998/wjcc.v11.i10.2140
Published online Apr 6, 2023. doi: 10.12998/wjcc.v11.i10.2140
Figure 1 Risk factors for severe disease in liver transplantation recipients with coronavirus disease 2019.
MMF: Mycophenolate mofetil.
Figure 2 Management of liver transplantation recipients infected with coronavirus disease 2019.
COVID-19: Coronavirus disease 2019; LT: Liver transplantation; HFNC: High flow nasal canula; HTCP: High-titer convalescent plasma; IL-6: Interleukin 6; JAK: Janus kinase; LT: Liver transplant; MV: Mechanical ventilation; NIV: Noninvasive ventilation.
- Citation: Hashem M, El-Kassas M. Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19. World J Clin Cases 2023; 11(10): 2140-2159
- URL: https://www.wjgnet.com/2307-8960/full/v11/i10/2140.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i10.2140